galactosamine has been researched along with Hepatorenal Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Li, XR; Wang, HT; Wang, JB; Wang, W; Wang, Y; Yang, S; Zhang, MX; Zhao, YT | 1 |
| Gao, WS; Li, LP; Liu, JY; Wang, HT; Wang, JB; Wang, W; Yan, YC; Zhang, MX; Zhao, YT | 1 |
| Kozłowski, W; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Wesołowski, P | 2 |
| Kozłowski, W; Saracyn, M; Wańikowicz, Z | 1 |
| Cui, W; Liu, P; Wen, Y | 1 |
| Anand, R; Dashwood, M; Goodier, D; Harry, D; Holt, S; Jarmulowicz, M; Milner, P; Moore, K | 1 |
7 other study(ies) available for galactosamine and Hepatorenal Syndrome
| Article | Year |
|---|---|
High expression of type I inositol 1,4,5-trisphosphate receptor in the kidney of rats with hepatorenal syndrome.
Topics: Animals; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Humans; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Lipopolysaccharides; Liver; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Necrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Specific Pathogen-Free Organisms | 2018 |
Development of a rat model of D-galactosamine/lipopolysaccharide induced hepatorenal syndrome.
Topics: Animals; Cytokines; Disease Models, Animal; Galactosamine; Glomerular Filtration Rate; Hepatorenal Syndrome; Kidney; Lipopolysaccharides; Liver; Male; Necrosis; Rats, Sprague-Dawley; Time Factors | 2015 |
[Role of nitric oxide system in pathogenesis of experimental model of hepatorenal syndrome].
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Galactosamine; Hepatorenal Syndrome; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 2008 |
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome].
Topics: Alanine Transaminase; Ammonia; Animals; Bilirubin; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Kidney; Liver Failure; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Renal Insufficiency | 2008 |
[Description of an experimental model of hepatorenal syndrome in Wistar rats].
Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Kidney; Liver Failure; Male; Rats; Rats, Wistar | 2004 |
Type I inositol 1, 4, 5-triphosphate receptors increase in kidney of mice with fulminant hepatic failure.
Topics: Animals; Calcium Channels; Disease Models, Animal; Disease Progression; Galactosamine; Glomerular Mesangium; Hepatorenal Syndrome; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Lipopolysaccharides; Liver Failure, Acute; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Up-Regulation | 2007 |
Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.
Topics: Acute Disease; Analysis of Variance; Animals; Antihypertensive Agents; Biomarkers; Bosentan; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Galactosamine; Hepatorenal Syndrome; Male; Microscopy, Electron; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Renal Circulation; Statistics, Nonparametric; Sulfonamides; Up-Regulation | 2002 |